
Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder
Author(s) -
Citrome L.
Publication year - 2011
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1111/j.1742-1241.2010.02615.x
Subject(s) - medicine , bipolar disorder , antipsychotic , schizophrenia (object oriented programming) , placebo , anesthesia , psychiatry , lithium (medication) , alternative medicine , pathology
To describe the efficacy and safety of inhaled loxapine, a new formulation of an older antipsychotic being developed for the treatment of agitation associated with schizophrenia or bipolar disorder.